The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia

Objectives: The COVID-19 pandemic disrupted service provision of harm reduction and drug treatment services for people who inject drugs in many countries. The two supervised injecting facilities (SIFs) in Sydney and Melbourne were differentially impacted by the pandemic, requiring local procedural c...

Full description

Bibliographic Details
Main Authors: Roxburgh, A., Livingston, Michael, Dietze, Paul, Nielsen, S., Cogger, S., Bartlett, M., Day, C., Latimer, J., Jauncey, M., Clark, N.
Format: Journal Article
Language:English
Published: 2023
Subjects:
Online Access:http://purl.org/au-research/grants/nhmrc/1173505
http://hdl.handle.net/20.500.11937/96544
_version_ 1848766167755259904
author Roxburgh, A.
Livingston, Michael
Dietze, Paul
Nielsen, S.
Cogger, S.
Bartlett, M.
Day, C.
Latimer, J.
Jauncey, M.
Clark, N.
author_facet Roxburgh, A.
Livingston, Michael
Dietze, Paul
Nielsen, S.
Cogger, S.
Bartlett, M.
Day, C.
Latimer, J.
Jauncey, M.
Clark, N.
author_sort Roxburgh, A.
building Curtin Institutional Repository
collection Online Access
description Objectives: The COVID-19 pandemic disrupted service provision of harm reduction and drug treatment services for people who inject drugs in many countries. The two supervised injecting facilities (SIFs) in Sydney and Melbourne were differentially impacted by the pandemic, requiring local procedural changes in each service. We aimed to examine the impact of pandemic responses (including restrictions on movement, known as ‘lockdowns’) on service use and key parameters such as client reports of drug injected and recorded overdose rates. Study design: Time series analysis of weekly client visits and monthly overdoses occurring at each service. Methods: Administrative client data from the two SIFs (Sydney data from 1 January 2018 to 30 April 2022; Melbourne data from 1 July 2018 to 30 April 2022) were examined using interrupted time series analyses with lockdown dates in each state entered as interruption terms. We analysed weekly SIF visits overall and by drug type, and monthly rates of opioid overdose at each service. Results: Lockdowns resulted in decreased visits to both services. The number of weekly client visits decreased during the first national lockdown for both the Sydney (trend change = −57.9; 95% CI [−109.4, −6.4]) and Melbourne SIF (near sig trend change = −54.8 [−110.8, 1.05]). Trends in visit numbers increased after lockdowns were lifted in each city; however, visits in Sydney have not returned to the numbers recorded prior to the pandemic. Visits to the Melbourne SIF related to heroin use declined at each lockdown (trend 1 = −42.7 [−81.5, −3.9]; trend 2 = −56.1 [−94.6, −17.7]; trend 3 = −33.8 [−67.4, −0.2]); heroin visits to the Sydney SIF declined during the first lockdown and remained low (trend = −55.6 [−82.8, −28.3]). Methamphetamine visits to the Sydney SIF fluctuated, surpassing heroin visits at several timepoints. Rates of monthly opioid overdoses at both services declined immediately following the start of the first lockdown (Sydney = −16.6 [−26.1, −6.8]; Melbourne = −6.4 [−8.7, −4.1]), with increasing trends recorded at the end of the final lockdown in each jurisdiction (Sydney = 2.8 [0.6, 5.0]; Melbourne = 1.3 [0.72, 3.2]). Conclusions: Public health restrictions related to the COVID-19 pandemic were associated with reduced client visits to, and overdoses in, Australian SIFs. Variations were noted in the drugs injected, likely reflecting changes in local drug markets. Shifts to other drugs during these periods were evident: methamphetamine in Sydney; co-injection of heroin and diphenhydramine in Melbourne.
first_indexed 2025-11-14T11:46:51Z
format Journal Article
id curtin-20.500.11937-96544
institution Curtin University Malaysia
institution_category Local University
language eng
last_indexed 2025-11-14T11:46:51Z
publishDate 2023
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-965442025-01-17T01:40:42Z The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia Roxburgh, A. Livingston, Michael Dietze, Paul Nielsen, S. Cogger, S. Bartlett, M. Day, C. Latimer, J. Jauncey, M. Clark, N. COVID-19 Harm reduction Injecting drug use Overdose Supervised injecting facilities Time series Humans COVID-19 Drug Overdose Australia Substance Abuse, Intravenous Needle-Exchange Programs Harm Reduction Interrupted Time Series Analysis SARS-CoV-2 Pandemics Public Health Humans Substance Abuse, Intravenous Harm Reduction Public Health Needle-Exchange Programs Australia Pandemics Drug Overdose Interrupted Time Series Analysis COVID-19 SARS-CoV-2 Objectives: The COVID-19 pandemic disrupted service provision of harm reduction and drug treatment services for people who inject drugs in many countries. The two supervised injecting facilities (SIFs) in Sydney and Melbourne were differentially impacted by the pandemic, requiring local procedural changes in each service. We aimed to examine the impact of pandemic responses (including restrictions on movement, known as ‘lockdowns’) on service use and key parameters such as client reports of drug injected and recorded overdose rates. Study design: Time series analysis of weekly client visits and monthly overdoses occurring at each service. Methods: Administrative client data from the two SIFs (Sydney data from 1 January 2018 to 30 April 2022; Melbourne data from 1 July 2018 to 30 April 2022) were examined using interrupted time series analyses with lockdown dates in each state entered as interruption terms. We analysed weekly SIF visits overall and by drug type, and monthly rates of opioid overdose at each service. Results: Lockdowns resulted in decreased visits to both services. The number of weekly client visits decreased during the first national lockdown for both the Sydney (trend change = −57.9; 95% CI [−109.4, −6.4]) and Melbourne SIF (near sig trend change = −54.8 [−110.8, 1.05]). Trends in visit numbers increased after lockdowns were lifted in each city; however, visits in Sydney have not returned to the numbers recorded prior to the pandemic. Visits to the Melbourne SIF related to heroin use declined at each lockdown (trend 1 = −42.7 [−81.5, −3.9]; trend 2 = −56.1 [−94.6, −17.7]; trend 3 = −33.8 [−67.4, −0.2]); heroin visits to the Sydney SIF declined during the first lockdown and remained low (trend = −55.6 [−82.8, −28.3]). Methamphetamine visits to the Sydney SIF fluctuated, surpassing heroin visits at several timepoints. Rates of monthly opioid overdoses at both services declined immediately following the start of the first lockdown (Sydney = −16.6 [−26.1, −6.8]; Melbourne = −6.4 [−8.7, −4.1]), with increasing trends recorded at the end of the final lockdown in each jurisdiction (Sydney = 2.8 [0.6, 5.0]; Melbourne = 1.3 [0.72, 3.2]). Conclusions: Public health restrictions related to the COVID-19 pandemic were associated with reduced client visits to, and overdoses in, Australian SIFs. Variations were noted in the drugs injected, likely reflecting changes in local drug markets. Shifts to other drugs during these periods were evident: methamphetamine in Sydney; co-injection of heroin and diphenhydramine in Melbourne. 2023 Journal Article http://hdl.handle.net/20.500.11937/96544 10.1016/j.puhe.2023.08.019 eng http://purl.org/au-research/grants/nhmrc/1173505 http://purl.org/au-research/grants/arc/FT210100656 http://creativecommons.org/licenses/by-nc-nd/4.0/ fulltext
spellingShingle COVID-19
Harm reduction
Injecting drug use
Overdose
Supervised injecting facilities
Time series
Humans
COVID-19
Drug Overdose
Australia
Substance Abuse, Intravenous
Needle-Exchange Programs
Harm Reduction
Interrupted Time Series Analysis
SARS-CoV-2
Pandemics
Public Health
Humans
Substance Abuse, Intravenous
Harm Reduction
Public Health
Needle-Exchange Programs
Australia
Pandemics
Drug Overdose
Interrupted Time Series Analysis
COVID-19
SARS-CoV-2
Roxburgh, A.
Livingston, Michael
Dietze, Paul
Nielsen, S.
Cogger, S.
Bartlett, M.
Day, C.
Latimer, J.
Jauncey, M.
Clark, N.
The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
title The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
title_full The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
title_fullStr The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
title_full_unstemmed The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
title_short The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia
title_sort impact of covid-19 public health measures on attendance and overdose at supervised injecting facilities in australia
topic COVID-19
Harm reduction
Injecting drug use
Overdose
Supervised injecting facilities
Time series
Humans
COVID-19
Drug Overdose
Australia
Substance Abuse, Intravenous
Needle-Exchange Programs
Harm Reduction
Interrupted Time Series Analysis
SARS-CoV-2
Pandemics
Public Health
Humans
Substance Abuse, Intravenous
Harm Reduction
Public Health
Needle-Exchange Programs
Australia
Pandemics
Drug Overdose
Interrupted Time Series Analysis
COVID-19
SARS-CoV-2
url http://purl.org/au-research/grants/nhmrc/1173505
http://purl.org/au-research/grants/nhmrc/1173505
http://hdl.handle.net/20.500.11937/96544